cobas EGFR Mutation Test v2
FDA-approved real-time PCR EGFR companion diagnostic for NSCLC.
- Developer
- Roche
- Intended use
- Other
- Cancer scope
- Non-small cell lung cancer
- Specimen
- FFPE tumor tissue, Plasma
- Molecular modality
- DNA mutation
- Current version
- cobas EGFR Mutation Test v2 current P120019/S043 lineage (2026)
- Evidence context
- 0 structured studies · 0 indexed performance results · 5 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.